Vorobcsuk A - Search Results

1

Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity.

Aradi D, Rideg O, Vorobcsuk A, Magyarlaki T, Magyari B, Kónyi A, Pintér T, Horváth IG, Komócsi A. Aradi D, et al. Among authors: vorobcsuk a. Eur J Clin Invest. 2012 Apr;42(4):384-92. doi: 10.1111/j.1365-2362.2011.02594.x. Epub 2011 Sep 9. Eur J Clin Invest. 2012. PMID: 21902692 Clinical Trial.

2

Optimizing clopidogrel therapy before stent implantation: should clinical setting be taken into account?

Aradi D, Vorobcsuk A, Komócsi A. Aradi D, et al. Among authors: vorobcsuk a. J Am Coll Cardiol. 2008 Oct 14;52(16):1349; author reply 1349-50. doi: 10.1016/j.jacc.2008.05.063. J Am Coll Cardiol. 2008. PMID: 18929249 Free article. No abstract available.

3

Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction Systematic overview and meta-analysis.

Vorobcsuk A, Kónyi A, Aradi D, Horváth IG, Ungi I, Louvard Y, Komócsi A. Vorobcsuk A, et al. Am Heart J. 2009 Nov;158(5):814-21. doi: 10.1016/j.ahj.2009.08.022. Am Heart J. 2009. PMID: 19853703

4

Low platelet disaggregation predicts poor response to 150 mg clopidogrel in patients with elevated platelet reactivity.

Aradi D, Vorobcsuk A, Lenkey Z, Horváth IG, Komócsi A. Aradi D, et al. Among authors: vorobcsuk a. Platelets. 2010;21(1):1-10. doi: 10.3109/09537100903391015. Platelets. 2010. PMID: 19929306 Free article.

5

Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition.

Aradi D, Magyarlaki T, Tokés-Füzesi M, Rideg O, Vorobcsuk A, Komócsi A. Aradi D, et al. Among authors: vorobcsuk a. Platelets. 2010;21(7):563-70. doi: 10.3109/09537104.2010.494742. Platelets. 2010. PMID: 20642320 Free article.

6

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis.

Aradi D, Komócsi A, Vorobcsuk A, Rideg O, Tokés-Füzesi M, Magyarlaki T, Horváth IG, Serebruany VL. Aradi D, et al. Among authors: vorobcsuk a. Am Heart J. 2010 Sep;160(3):543-51. doi: 10.1016/j.ahj.2010.06.004. Am Heart J. 2010. PMID: 20826265

7

Outcomes of patients receiving clopidogrel prior to cardiac surgery.

Vorobcsuk A, Aradi D, Farkasfalvi K, Horváth IG, Komócsi A. Vorobcsuk A, et al. Int J Cardiol. 2012 Apr 5;156(1):34-40. doi: 10.1016/j.ijcard.2010.10.034. Epub 2010 Nov 26. Int J Cardiol. 2012. PMID: 21112646 Review.

8

Mechanism of coronary flow reserve reduction in systemic sclerosis: insight from intracoronary pressure wire studies.

Pintér T, Faludi R, Magyari B, Vorobcsuk A, Kumánovics G, Minier T, Czirják L, Komócsi A. Pintér T, et al. Among authors: vorobcsuk a. Rheumatology (Oxford). 2011 Apr;50(4):781-8. doi: 10.1093/rheumatology/keq402. Epub 2010 Dec 13. Rheumatology (Oxford). 2011. PMID: 21156672

9

The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies.

Komócsi A, Vorobcsuk A, Faludi R, Pintér T, Lenkey Z, Költo G, Czirják L. Komócsi A, et al. Among authors: vorobcsuk a. Rheumatology (Oxford). 2012 Jun;51(6):1027-36. doi: 10.1093/rheumatology/ker357. Epub 2012 Jan 5. Rheumatology (Oxford). 2012. PMID: 22223705

10

Use of new-generation oral anticoagulant agents in patients receiving antiplatelet therapy after an acute coronary syndrome: systematic review and meta-analysis of randomized controlled trials.

Komócsi A, Vorobcsuk A, Kehl D, Aradi D. Komócsi A, et al. Among authors: vorobcsuk a. Arch Intern Med. 2012 Nov 12;172(20):1537-45. doi: 10.1001/archinternmed.2012.4026. Arch Intern Med. 2012. PMID: 23007264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters